In a modeling study of women vaccinated against human papillomavirus (HPV), researchers found that cervical cancer screening could be done far less often than current recommendations without compromising health benefits. For women vaccinated at younger ages, screening just two or three times over a lifetime was both cost‑effective and associated with fewer unnecessary follow‑up procedures, suggesting that existing screening guidelines may be overly intensive for this growing population.
This article was originally published on MedicalXpress.com
